Scholar Rock

Read more
Tony Kingsley's photo - President & CEO of Scholar Rock

President & CEO

Tony Kingsley

CEO Approval Rating

90/100

Founded:

2012

Status:

PublicIndependent CompanyNASDAQSRRK

SCHOLAR ROCK TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Merck is one of Scholar Rock's top rivals. Merck is a Public company that was founded in 1891 in Kenilworth, New Jersey. Like Scholar Rock, Merck also works within the Biotechnology industry. Compared to Scholar Rock, Merck has 73,935 more employees.

Sanofi is seen as one of Scholar Rock's biggest rivals. Sanofi was founded in 1994 in Paris, Île-de-France. Sanofi competes in the Pharmaceuticals industry. Sanofi generates $44.4B more revenue than Scholar Rock.

Novartis is one of Scholar Rock's top competitors. Novartis was founded in 1996, and its headquarters is in Basel, Basel-City. Novartis is in the Pharmaceuticals industry. Novartis has 109,935 more employees than Scholar Rock.

Scholar Rock Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$15.1M

Scholar Rock's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 8.8B. Over the last four quarters, Scholar Rock's revenue has grown by 20.7%. Specifically, in Q1 2021's revenue was $4.7M; in Q4 2020, it was $3.4M; in Q3 2020, it was $3M; in Q2 2020, Scholar Rock's revenue was $3.9M.

Scholar Rock Acquisitions

No recent acquisitions found related to Scholar Rock

Scholar Rock Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Oct 2020
$50M
IPO
May 2018
$75M

Series C
Jan 2018
$47M
Series B
Dec 2015
$36.3M
Series A
Sep 2014
$20M

Scholar Rock Investments

No recent investments found related to Scholar Rock

Scholar Rock News

Scholar Rock Press Releases

Social Media

Scholar Rock Headquarters

301 Binney Street 3rd Floor

Cambridge, Massachusetts02142

857-259-3860

Driving Directions »

Trending Companies

Scholar Rock Summary

ABOUT

Overview

Scholar Rock is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer and anemia. Scholar Rock was founded in 2012. Scholar Rock's headquarters is located in Cambridge, Massachusetts, USA 02142. It...

CEO

Scholar Rock's President & CEO, Tony Kingsley, currently has an approval rating of 90%. Scholar Rock's primary competitors are Merck, Sanofi & Novartis.

Frequently Asked Questions about Scholar Rock

  1. When was Scholar Rock founded?

    Scholar Rock was founded in 2012
  2. Who is Scholar Rock's CEO?

    Scholar Rock's CEO is Tony Kingsley
  3. How much revenue does Scholar Rock generate?

    Scholar Rock generates $15.1M in revenue
  4. How much funding does Scholar Rock have?

    Scholar Rock has historically raised $228.3M in funding
  1. Where is Scholar Rock's headquarters?

    Scholar Rock's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Scholar Rock have?

    Scholar Rock has 65 employees
  3. What sector does Scholar Rock operate in?

    Scholar Rock is in Biotechnology
  4. Who are Scholar Rock's competitors?

    Scholar Rock's top competitors are Merck, Sanofi, Novartis